medpagetoday.com/Endocrinolo … gy/tb/6538
“Exogenous therapy with pulsatile GnRH or gonadotropin therapy usually restores normal pubertal development and fertility, whereas androgen therapy only induces virilization.”
I suppose such “gonadotropin therapy” would be analagous to SERM therapy in its mechanism and purpose…
I realize this source has as its focus therapeutic initiation of puberty, which, wonder, may perhaps be similar in mechanism to what we know and care about as “jumpstarting the HPTA?”
But the point is, if there are differences in pulsatile GnRH therapy and androgen therapy, as far as treatment is concerned, which one should really be preferred?
It makes sense to me that by keeping gonadotropins going, one might be in a better position to perhaps eventually restore HPTA function, as they do for restoring puberty.